Showing 1 - 12 results of 12 for search 'Yamin Shu', query time: 0.04s
Refine Results
-
1
A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data by Qilin Zhang, Yiling Ding, Yamin Shu, Jing Chen
Published 2023-08-01
Article -
2
-
3
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib by Yanchao Yin, Yamin Shu, Junru Zhu, Feie Li, Juan Li
Published 2022-11-01
Article -
4
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib by Menglin Guo, Yamin Shu, Guosong Chen, Juan Li, Feie Li
Published 2022-11-01
Article -
5
-
6
-
7
-
8
-
9
-
10
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax. by Yang Yang, Yamin Shu, Guosong Chen, Yanchao Yin, Feie Li, Juan Li
Published 2022-01-01
Article -
11
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax by Yang Yang, Yamin Shu, Guosong Chen, Yanchao Yin, Feie Li, Juan Li
Published 2022-01-01
Article -
12